{
    "Trade/Device Name(s)": [
        "Elecsys HSV-1 IgG Immunoassay",
        "PreciControl HSV"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K120625",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000238",
        "K081338"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ",
        "JJX"
    ],
    "Summary Letter Date": "June 25, 2012",
    "Summary Letter Received Date": "June 26, 2012",
    "Submission Date": "February 29, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.3305",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "HSV-1 IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium-heparin plasma",
        "K2 EDTA plasma",
        "K3 EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010",
        "MODULAR ANALYTICS E170",
        "cobas e 411",
        "cobas e 601",
        "cobas e 602"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescent immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Elecsys HSV-1 IgG immunoassay and PreciControl HSV for qualitative detection of HSV-1 IgG antibodies on Elecsys and cobas e analyzers.",
    "Indications for Use Summary": "Qualitative determination of IgG antibodies to HSV-1 in human serum and specified plasma types to aid presumptive diagnosis of HSV-1 infection in sexually active individuals and expectant mothers; PreciControl HSV is for quality control of the assay on Elecsys and cobas e analyzers.",
    "fda_folder": "Microbiology"
}